Is OGEN or OMER more undervalued in 2026?

CirclFi compares Oragenics Inc. (OGEN) and Omeros Corporation (OMER) using 13 institutional-grade valuation models. OGEN has a Quality of Company score of 4.5/10 while OMER scores 3.3/10.

Which is a better buy — OGEN or OMER?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OGEN and OMER valuations compare?

OGEN at $0.60 and OMER at $11.15 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OGEN vs OMER Valuation Comparison 2026 — Intrinsic Value Analysis

OGEN

Biotechnology

Oragenics Inc.

Quality

4.5

out of 10

Value Trap

SAFE

Price

$0.60

Last close

Models

6/13

Active

OMER

Biotechnology

Omeros Corporation

Quality

3.3

out of 10

Value Trap

LOW

Price

$11.15

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	OGEN Fair Value	OGEN Upside	OMER Fair Value	OMER Upside
Bayesian DCF	Intrinsic	$0.90	+49.9%	$2.45	-78.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.14	-76.9%	$4.10	-63.3%
Dynamic NAV	Asset-Based	—	—	$3.03	-72.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OGEN vs OMER — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OGEN vs OMER — Which Stock Is More Undervalued?

OGEN scores higher with a 4.5/10 quality rating vs OMER's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Oragenics Inc. (OGEN) and Omeros Corporation (OMER) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OGEN currently trades at $0.60 with a QOC of 4.5/10, while OMER trades at $11.15 with a QOC of 3.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).